246 related articles for article (PubMed ID: 23624626)
1. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
Mishra S; Guan J; Plovie E; Seldin DC; Connors LH; Merlini G; Falk RH; MacRae CA; Liao R
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H95-103. PubMed ID: 23624626
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.
Mishra S; Joshi S; Ward JE; Buys EP; Mishra D; Mishra D; Morgado I; Fisch S; Lavatelli F; Merlini G; Dorbala S; MacRae CA; Liao R
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1158-H1166. PubMed ID: 30875258
[TBL] [Abstract][Full Text] [Related]
3. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
Guan J; Mishra S; Shi J; Plovie E; Qiu Y; Cao X; Gianni D; Jiang B; Del Monte F; Connors LH; Seldin DC; Lavatelli F; Rognoni P; Palladini G; Merlini G; Falk RH; Semigran MJ; Dec GW; Macrae CA; Liao R
Basic Res Cardiol; 2013 Sep; 108(5):378. PubMed ID: 23982491
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report.
Shin JT; Ward JE; Collins PA; Dai M; Semigran HL; Semigran MJ; Seldin DC
Amyloid; 2012 Dec; 19(4):191-6. PubMed ID: 23126591
[TBL] [Abstract][Full Text] [Related]
5. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.
Shi J; Guan J; Jiang B; Brenner DA; Del Monte F; Ward JE; Connors LH; Sawyer DB; Semigran MJ; Macgillivray TE; Seldin DC; Falk R; Liao R
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4188-93. PubMed ID: 20150510
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.
Guan J; Mishra S; Qiu Y; Shi J; Trudeau K; Las G; Liesa M; Shirihai OS; Connors LH; Seldin DC; Falk RH; MacRae CA; Liao R
EMBO Mol Med; 2014 Nov; 6(11):1493-507. PubMed ID: 25319546
[TBL] [Abstract][Full Text] [Related]
7. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.
Brenner DA; Jain M; Pimentel DR; Wang B; Connors LH; Skinner M; Apstein CS; Liao R
Circ Res; 2004 Apr; 94(8):1008-10. PubMed ID: 15044325
[TBL] [Abstract][Full Text] [Related]
8. Harnessing Cardiac Regeneration as a Potential Therapeutic Strategy for AL Cardiac Amyloidosis.
Joshi S; Evangelisti A; Liao R; Alexander KM
Curr Cardiol Rep; 2020 Jan; 22(1):1. PubMed ID: 31932992
[TBL] [Abstract][Full Text] [Related]
9. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.
Liao R; Jain M; Teller P; Connors LH; Ngoy S; Skinner M; Falk RH; Apstein CS
Circulation; 2001 Oct; 104(14):1594-7. PubMed ID: 11581134
[TBL] [Abstract][Full Text] [Related]
10. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.
Imperlini E; Gnecchi M; Rognoni P; Sabidò E; Ciuffreda MC; Palladini G; Espadas G; Mancuso FM; Bozzola M; Malpasso G; Valentini V; Palladini G; Orrù S; Ferraro G; Milani P; Perlini S; Salvatore F; Merlini G; Lavatelli F
Sci Rep; 2017 Nov; 7(1):15661. PubMed ID: 29142197
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
[TBL] [Abstract][Full Text] [Related]
12. A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity.
Cheng H; Kari G; Dicker AP; Rodeck U; Koch WJ; Force T
Circ Res; 2011 Dec; 109(12):1401-9. PubMed ID: 21998323
[TBL] [Abstract][Full Text] [Related]
13. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H
J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823
[TBL] [Abstract][Full Text] [Related]
14. Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis.
Lavatelli F; Imperlini E; Orrù S; Rognoni P; Sarnataro D; Palladini G; Malpasso G; Soriano ME; Di Fonzo A; Valentini V; Gnecchi M; Perlini S; Salvatore F; Merlini G
FASEB J; 2015 Nov; 29(11):4614-28. PubMed ID: 26220173
[TBL] [Abstract][Full Text] [Related]
15. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
Grogan M; Dispenzieri A; Gertz MA
Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
[TBL] [Abstract][Full Text] [Related]
16. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
Tanaka K; Essick EE; Doros G; Tanriverdi K; Connors LH; Seldin DC; Sam F
J Am Heart Assoc; 2013 Mar; 2(2):e005868. PubMed ID: 23537813
[TBL] [Abstract][Full Text] [Related]
17. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
Elife; 2020 Mar; 9():. PubMed ID: 32151314
[TBL] [Abstract][Full Text] [Related]
18. 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis
Renz M; Torres R; Dolan PJ; Tam SJ; Tapia JR; Li L; Salmans JR; Barbour RM; Shughrue PJ; Nijjar T; Schenk D; Kinney GG; Zago W
Amyloid; 2016 Sep; 23(3):168-177. PubMed ID: 27494229
[TBL] [Abstract][Full Text] [Related]
19. Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart.
Koczor CA; Ludlow I; Hight RS; Jiao Z; Fields E; Ludaway T; Russ R; Torres RA; Lewis W
Toxicol Sci; 2015 Nov; 148(1):183-91. PubMed ID: 26251327
[TBL] [Abstract][Full Text] [Related]
20. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
